PROCESS FOR PRODUCING L-AMINO ACIDS

Abstract: A process for producing L-amino acids comprising incubating microorganisms which are capable of producing L-amino acids, in particular, L-phenylalanine, L-tryptophan, L-tyrosine, L-threonine or L-isoleucine and have an enhanced productivity of phosphoenolpyruvic acid in a medium and taking up the L-amino acids thus produced and accumulated in the medium.

Description: Technical Field The present invention relates to a method for producing L-amino acids. In particular, the present invention relates to a method for efficiently producing amino acids for which the demand rapidly increases, such as those used as feed additives (L-threonine), and raw materials for pharmaceuticals such as infusion solutions (L-threonine and L-isoleucine). Background Art There are a large number of methods for producing amino acids based on the use of the microorganisms. For example, methods for producing L-phenylalanine are known, including those based on the use of recombinants of Escherichia coli ( E. coli ) as disclosed in Japanese Patent Publication No. 2-4276, Japanese Laid-Open Patent Publication (PCT) No. 4-501813, Japanese Laid-Open Patent Publication No. 5-244956, and International Publication WO87/00202. Methods for producing L-phenylalanine or L-tyrosine are also known, including those based on the use of a mutant strain belonging to the genus Corynebacterium as disclosed in Japanese Laid-Open Patent Publication No. 61-128897, and those based on the use of a recombinant of a Corynebacterium strain as disclosed in Japanese Laid-Open Patent Publication Nos. 60-34197, 60-24192, 61-260892, and 61-124375. Methods for producing L-tryptophane have been reported, including those based on the use of a recombinant of Escherichia coli as disclosed in Japanese Laid-Open Patent Publication No. 57-71397 and United States Patent No. 4,371,614, those based on the use of a mutant strain of Bacillus subtilis as disclosed in Japanese Patent Publication Nos. 53-39517 and 62-34399, those based on the use of a recombinant of Bacillus subtilis as disclosed in Japanese Laid-Open Patent Publication Nos. 61-104790 and 1-67179, those based on the use of a mutant strain belonging to the genus Brevibacterium as disclosed in Japanese Laid-Open Patent Publication No. 57-174096, and those based on the use of a recombinant belonging to the genus Brevibacterium as disclosed in Japanese Laid-Open Patent Publication No. 62-51980. Methods for producing L-threonine have been reported, including those based on the use of a mutant strain belonging to the genus Escherichia as disclosed in Japanese Laid-Open Patent Publication No. 5-304969, those based on the use of a recombinant of Escherichia coli as disclosed in Japanese Patent Publication No. 1-29559, Japanese Laid-Open Patent Publication Nos. 2-109985 and 56-15696, and Japanese Laid-Open Patent Publication (PCT) No. 3-501682. Further, there have been reported those based on the use of a mutant strain of a bacterium belonging to the genus Corynebacterium as disclosed in Japanese Laid-Open Patent Publication No. 62-239996, and those based on the use of a recombinant bacterium belonging to the genus Corynebacterium as disclosed in Japanese Laid-Open Patent Publication No. 61-195695. Methods for producing L-isoleucine have been reported, including those based on the use of Escherichia coli as disclosed in Japanese Laid-Open Patent Publication No. 5-130882, and those based on the use of a recombinant of Escherichia coli as disclosed in Japanese Laid-Open Patent Publication No. 2-458. Further, there have been reported those based on the use of a mutant strain of a bacterium belonging to the genus Corynebacterium as disclosed in Japanese Patent Publication No. 3-62395, and those based on the use of a recombinant belonging to the genus Corynebacterium as disclosed in Japanese Patent Publication No. 5-47196. The microorganisms, which have been used in the methods for producing amino acid as described above, have been bred principally on the basis of the enhancement of enzymes for catalyzing reactions in common pathways for various amino acids and in inherent pathways subsequent thereto for individual amino acids, or on the basis of the avoidance of control effected by final products or the like (feedback inhibition and suppression). Specifically, those which have been employed for the breeding include, for example, addition of auxotrophy to the microorganism, addition of drug resistance, and amplification of enzyme genes concerning the biosynthesis system and introduction of mutation aimed at desensitization of control based on the recombinant DNA technique. The enzyme, which is in charge of the first reaction in the common pathway of aromatic amino acid biosynthesis, is 3-deoxy-D-arabino-hepturonate-7-phosphate (DAHP) synthase (DS). DS of Escherichia coli includes three types of isozymes which are encoded by genes called aroF , aroG , and aroH respectively and which undergo feedback inhibition by L-tyrosine, L-phenylalanine, and L-tryptophane respectively. Concerning these genes, a technique for improving the productivity of aromatic amino acid is known, which is based on the introduction, into Escherichia coli , of a combination of a gene coding for a desensitized type enzyme (enzyme substantially not subjected to feedback inhibition) originating from aroF or aroG involving high enzyme activity and a tryptophane operon containing a gene coding for a desensitized type anthranilate synthase (AS) of the inherent system of L-tryptophane biosynthesis. Phosphoenolpyruvic acid (hereinafter referred to as "PEP", if necessary) and D-erythrose 4-phosphate (E4P) are used as substrates in the synthetic reaction for DAHP. PEP also serves as precursors for biosynthesis of L-aspartic acid, L-threonine, L-isoleucine and the like. The substrates as described above are supplied from a carbon source such as glucose via the glycolytic pathway and the pentose phosphate pathway. However, no case has been hitherto known in the breeding of amino acid-producing strains, in which the ability to supply such substrates is enhanced to improve the productivity of amino acids. Phosphoenolpyruvate synthase (hereinafter abbreviated as "PPS", if necessary) is an enzyme which is broadly found in microorganisms. This enzyme plays an important role to supply PEP from pyruvic acid in glyconeogenesis. Escherichia coli , which is a bacterium belonging to the genus Escherichia , has been used to perform cloning of a gene ( pps ) coding for PPS, determination of the nucleotide sequence of the gene, and functional analysis for the enzyme. Besides, it has been reported that DAHP is produced at a value approximate to the theoretical yield by means of simultaneous amplification of the pps gene and the transketorase gene in a dehydroquinate synthase-deficient strain (Patnaik, R. et al., Appl. Environ. Mircobiol. , Vol. 60, No. 11, 3903-3908 (1994)). However, there has been known no case in which amplification of the pps gene enhances the productivity of aromatic amino acids and other amino acids. US 4,968,609 discloses a process for producing an aromatic amino acid comprising culturing a Coryneform bacterium carrying a recombinant DNA molecule coding for 3-deoxy-D-arabinoheptulosonate 7-phosphate (DAHP) synthase. Patnaik et al., Applied and Environmental Microbiology, Nov. 1994, p.3903-3908, disclose in the context of the production of aromatic amino acids in E.coli and other microorganisms that an overexpression of PEP synthase results in an increase of DAHP and thus an increase of aromatic metabolizes. Disclosure of the Invention An object of the present invention is to provide a method for producing particular non-aromatic amino acids inexpensively and at a high yield. The present inventors have found out that the productivity of the L-amino acids L-threonine and L-isolencine can be improved by enhancing the activity of phosphoenolpyruvate synthase in cells of a microorganism which has the L-amino acid-producing ability. Thus, the present invention has been completed. That is, the present invention lies in a method for producing L-amino acids comprising the steps of cultivating, in a medium, a microorganism having an L-amino acid-producing ability, producing and accumulating the L-amino acid in the medium, and collecting the L-amino acid, wherein: said L-amino acid is L-threonine or L-isoleucine and an activity of phosphoenolpyruvate synthase in microbial cells is enhanced as compound with a wild strain. The L-amino acid, which is produced by the production method described above, is L-threonine and L-isoleucine. The microorganism having the L-amino acid-producing ability is exemplified by bacteria belonging to the genus Escherichia and coryneform bacteria. The coryneform bacteria referred to herein include bacteria which have been hitherto classified into those belonging to the genus Brevibacterium but which are unified into bacteria belonging to the genus Corynebacterium at present ( Int. J. Syst. Bacteriol. , 41 , 255 (1991)). Further, the coryneform bacteria referred to herein include bacteria belonging to the genus Brevibacterium which are extremely closely related to the genus Corynebacterium . The means for enhancing the phosphoenolpyruvate-producing ability of the microorganism is to enhance an activity of PPS in microbial cells. Means for enhancing the activity of PPS in the microbial cells include, for example, a method to increase an amount of expression of a pps gene in the microbial cells, as well as a method to introduce, into the cells, a gene coding for PPS having a high specific activity. Specifically, means for increasing the amount of expression of the pps gene in the microbial cells include, for example, a method to increase the copy number of the pps gene in the microbial cells, as well as a method to enhance the transcriptive activity of a promoter for the pps gene. The present invention will be explained in detail below. The microorganism preferably used in the present invention is not specifically limited, and it includes, for example, microorganisms belonging to the genera Escherichia, Brevibacterium, Corynebacterium, Bacillus, Serratia , and Pseudomonas , provided that a DNA fragment containing a replication origin of a plasmid is obtained for the microorganism, the pps gene functions in the microorganism, the copy number of the pps gene can be increased in the microorganism, and the microorganism has the L-amino acid-producing ability (for example, in the case of L-phenylalanine, those acquired the L-phenylalanine-producing ability by conferring, for example, resistance to L-phenylalanine analog). Among them, those preferably used are bacteria belonging to the genus Escherichia and the coryneform bacteria. Specifically, those preferably used for L-threonine include, for example, Escherichia coli VKPM B-3996 (RIA 1867) (see United States Patent No. 5,175,107), and Corynebacterium acetoacidophilum AJ12318 (FERM BP-1172) (see United States Patent No. 5,188,949); and those preferably used for L-isoleucine include, for example, Escherichia coli KX141 (VKPM B-4781) (see European Patent Publication No. 519,113), and Brevibacterium flavum AJ12149 (FERM BP-759) (see United States Patent No. 4,656,135). The means for enhancing the PEP-producing ability of the microorganism as described above is the enhancement of the PPS activity in the microbial cells. The means for enhancing the PPS activity includes the increase of the amount of expression of the pps gene in the microbial cells. One of the means for enhancing the PPS activity is to modify the pps gene to create PPS having enhanced activity. The means for increasing the amount of expression of the pps gene in the microbial cells includes the increase of the copy number of the pps gene in the microbial cells. In order to increase the copy number of the pps gene, it is necessary to obtain a DNA fragment containing the same gene. The pps gene has been cloned in Escherichia coli as a bacterium belonging to the genus Escherichia , and its nucleotide sequence has been determined ( Mol. Gen. Genet. , 231 , 332 (1992)). Accordingly, the preparation of the DNA fragment containing the same gene is achieved by using a method disclosed in the document described above. A desired DNA fragment can be obtained by using a hybridization method based on the use of a synthetic DNA probe prepared with reference to the nucleotide sequence described above, or by using a PCR (Polymerase Chain Reaction) method based on the use of synthetic DNA primers prepared with reference to the same nucleotide sequence. The copy number of the pps gene can be increased by ligating the DNA fragment containing the pps gene with a vector DNA autonomously replicable in a target microorganism, and introducing an obtained recombinant DNA fragment into the same microorganism. The DNA primers, which are used to clone the pps gene from a bacterium belonging to the genus Escherichia by using the PCR method, can be appropriately prepared on the basis of, for example, a sequence known for Escherichia coli ( Mol. Gen. Genet. , 231 , 332 (1992)). Specifically, two primers of and are suitable, which make it possible to amplify a region of about 3.3 kb containing the pps gene. These primers make it possible to amplify the pps gene in a form of having Sal I cleavage ends at both terminals. When the restriction enzyme cleavage ends are introduced into the terminals of the PCR product, then the amplified DNA fragment is conveniently cloned by using the corresponding restriction enzyme, and the DNA fragment is conveniently transferred to another vector DNA. The primer DNA's can be synthesized, for example, by using a DNA synthesizer model 380B produced by Applied Biosystems in accordance with the phosphoamidite method (see Tetrahedron Letters , 22, 1859 (1981)). The PCR reaction can be performed, for example, by using DNA Thermal Cycler PJ2000 Type produced by Takara Shuzo and using Taq DNA polymerase in accordance with the method designated by the supplier. The DNA fragment containing the pps gene can be also obtained from microorganisms other than the bacteria belonging to the genus Escherichia . The method for obtaining the DNA fragment includes a hybridization method based on the use of a synthetic DNA probe prepared with reference to the nucleotide sequence disclosed in the document described above ( Mol. Gen. Genet. , 231 , 332 (1992)), or by using a PCR method based on the use of synthetic DNA primers prepared with reference to the same nucleotide sequence. The DNA probe used for the hybridization method can be also appropriately prepared on the basis of the known sequence in the same manner as the DNA primers used for the PCR method. It is assumed that the nucleotide sequence of the gene differs depending on respective microorganisms. Therefore, it is desirable to prepare synthetic DNA which pairs with a portion conserved for PPS of each of the microorganisms. When the pps gene amplified in accordance with the PCR method is introduced into a bacterium belonging to the genus Escherichia , then it is ligated with vector DNA autonomously replicable in cells of the bacterium belonging to the genus Escherichia , and obtained recombinant DNA is introduced into cells of the bacterium belonging to the genus Escherichia . When the obtained DNA fragment containing the pps gene is introduced into a microorganism other than the bacteria belonging to the genus Escherichia , the DNA fragment is ligated with vector DNA autonomously replicable in cells of the microorganism for introducing the DNA fragment thereinto, and obtained recombinant DNA is introduced into the cells. Plasmid vector DNA is preferably used as the vector DNA to be used in the present invention. When the microorganism into which the gene is introduced is Escherichia coli , those usable as the vector DNA include, for example, pTWV228, pUC19, pUC18, pBR322, pHSG299, pHSG399, and RSF1010. Besides, vectors composed of phage DNA may be utilized. In order to achieve efficient expression of PPS, it is also preferable to use a promoter which functions in the microorganism, such as lac , trp , and P L . In order to increase the copy number of the pps gene, it is also preferable to incorporate DNA containing the pps gene into the chromosome in accordance with the method based on the use of transposon (Berg, D. E. and Berg, C. M., Bio/Technol. , 1 , 417 (1983)), Mu phage (Japanese Laid-Open Patent Publication No. 2-109985), or homologous recombination ( Experiments in Molecular Genetics , Cold Spring Harbor Lab. (1972)). As for the vector DNA to be used in the present invention, when the microorganism into which the gene is introduced is the coryneform bacteria, those usable as the vector DNA include, for example, plasmid vectors autonomously replicable in the coryneform bacteria, such as pAM330 (see Japanese Patent Publication No. 1-11280) and pHM1519 (see Japanese Laid-Open Patent Publication No. 58-77895). Escherichia coli may be transformed with the recombinant vector obtained by inserting the DNA sequence of the present invention into the vector as described above, by using, for example, a method which is usually used for transformation of Escherichia coli , such as a method to enhance the permeability of DNA by treating cells with calcium chloride (Mandel, M. and Higa, A., J. Mol. Biol. , 53 , 159 (1977)). The method for transforming bacteria belonging to the genus Bacillus includes a method in which incorporation is performed during a specified growth period in which cells are able to incorporate DNA (report on Bacillus subtilis submitted by Duncan, C. H. et al). Further, DNA can be incorporated into bacterial cells by forming protoplast or spheroplast as DNA recipient which easily incorporates plasmid DNA. These methods are known for Bacillus subtilis , Actinomyces , and yeasts (Chang, S. et al., Molec. Gen. Genet. , 168 , 111 (1979); Bibb et al., Nature , 274 , 398 (1978); Hinnen, A. et al., Proc. Natl. Acad. Sci. USA , 75 , 1929 (1978)). The electroporation method, in which pores are instantaneously formed through cell walls by means of high voltage electric pulse so that DNA is incorporated (Hanahan, D. et al., Plasmid Transformation of Escherichia coli and other bacteria , Meth. Enzymol. , 204 , 63 (1991)), is also effective for a broad range of microbial cells. Besides, a transformation method based on the electroporation method for the coryneform bacteria is disclosed in Japanese Laid-Open Patent Publication No. 2-207791. In order to select a vector into which the pps gene is actually introduced, from candidate vectors which have the possibility of introduction of the pps gene, for example, a complementation test may be performed by using a PPS-deficient strain. The PPS-deficient strain cannot grow on a minimum medium containing pyruvic acid as a sole carbon source. Therefore, a transformant, which is capable of growing on this medium, may be selected. The PPS-deficient strain of Escherichia coli includes AT2572-1 strain (see J. Bacteriol. , 96 , 2185 (1968)). AT2572-1 strain is obtainable from E . coli Genetic Stock Center (Yale University, Dept. Biology, Osborn Memorial Labs., 06511-7444 New Haven, Connecticut, U.S.A., P.O. Box 6666, Strain No: CGSC5242). In order to select a strain in which the PPS activity is actually enhanced, from candidate strains which have the possibility of increase in the PPS activity, for example, a method is available, in which the increase in PPS enzyme activity is confirmed by using a known method (Cooper, R. A. and H. L. Kornberg, Meth. Enzymol. , 13 , 309 (1969)). The microorganism preferably used for the present invention includes those obtained by enhancing the PEP-producing ability of a microorganism which originally has the L-amino acid-producing ability, and those obtained by adding the L-amino acid-producing ability after enhancing the PEP-producing ability. Further, even in the case of a microorganism which originally has the L-amino acid-producing ability, the L-amino acid-producing ability is still more improved in some cases by enhancing an enzyme gene which is in charge of an inherent pathway in biosynthesis of the corresponding amino acid, or by introducing an operon or a gene which codes for a desensitized type (inhibition-desensitized type) enzyme of an enzyme which would be otherwise subjected to feedback inhibition. The gene or the operon as described above is exemplified by: those for L-threonine, including, for example, threonine operon having a gene coding for aspartokinase for which feedback inhibition by L-threonine is desensitized (Japanese Patent Publication No. 1-29559), a gene coding for homoserine dehydrogenase (Japanese Laid-Open Patent Publication No. 60-012995), and a gene coding for homoserine kinase and homoserine dehydrogenase (Japanese Laid-Open Patent Publication No. 61-195695); and those for L-isoleucine, including, for example, threonine operon described above and a gene coding for threonine deaminase for which feedback inhibition by L-threonine is desensitized (Japanese Laid-Open Patent Publication No. 2-458). The objective amino acid can be produced by cultivating the microorganism transformed with the recombinant DNA containing the pps gene obtained in accordance with the method described above, producing and accumulating the objective amino acid in a culture fluid, and collecting the objective amino acid. The medium used for the cultivation is an ordinary medium containing a carbon source, a nitrogen source, inorganic ions, and optionally other organic components. Those usable as the carbon source include, for example, sugars such as glucose, lactose, galactose, fructose, sucrose, and starch hydrolyzate; alcohols such as glycerol and sorbitol; and organic acids such as fumaric acid, citric acid, and succinic acid. Those usable as the nitrogen source include, for example, inorganic ammonium salts such as ammonium sulfate, ammonium chloride, and ammonium phosphate; organic nitrogen such as soybean hydrolyzate; ammonia gas; and aqueous ammonia. It is desirable to use, as the organic trace nutrient source, required substances such as vitamin B1 and vitamin B6, if necessary, as well as yeast extract or the like contained in an appropriate amount. Besides, for example, small amounts of potassium phosphate, magnesium sulfate, iron ion, and manganese ion are added, if necessary. The cultivation may be performed under a condition adapted to the microorganism to be used. Specifically, the cultivation is preferably carried out under an aerobic condition for 16 to 72 hours. The cultivation temperature is controlled to be 30 °C to 45 °C, and pH is controlled to be 5 to 7 during the cultivation. For the purpose of pH adjustment, it is possible to use, for example, inorganic or organic acidic or alkaline substances as well as ammonia gas. The L-amino acid can be collected from the fermentation fluid by combining known methods such as the ordinary ion exchange resin method, the precipitation method, and other methods. Brief Description of the Drawings Fig. 1 shows a procedure for constructing a plasmid pHSGSK. Fig. 2 shows a procedure for constructing a plasmid pdGM1. Fig. 3 shows a procedure for constructing a plasmid pMWGMA2. Fig. 4 shows a procedure for constructing a plasmid pMWD5. Best Mode for Carrying Out the Invention The present invention will be explained in further detail below with reference to Examples. Example 1: Preparation of pps gene of Escherichia coli Chromosomal DNA was extracted from W3110 strain originating from Escherichia coli K-12 in accordance with the method of Saito and Miura ( Biochem. Biophys. Acta , 72 , 619 (1963)). On the other hand, oligonucleotide primers to be used for amplifying the pps gene from the chromosomal DNA in accordance with the PCR method were synthesized on the basis of a known nucleotide sequence of the pps gene ( Mol. Gen. Genet. , 231, 332 (1992)). (1) (2) The primers mentioned above contain sequences homologous to or complementary to sequences located on upstream and downstream sides of the pps gene respectively, and they contain Sal I recognition sequences for facilitating cloning of the PCR product. The PCR reaction was carried out by using the chromosomal DNA and the primers described above in accordance with the method of Erlich ( PCR Technology , Stockton press (1989)). The reaction condition resided in a reaction cycle comprising thermal denaturation at 93 °C for 1 minute, annealing at 55 °C for 1.5 minute, and polymerase reaction at 72 °C for 3 minutes, the reaction cycle being repeated 30 times. A DNA fragment of 3.3 kbp obtained by the PCR reaction was digested with a restriction enzyme Sal I, followed by ligation to a Sal I site of a plasmid vector pTWV228 (ampicillin resistance (Ap r ), produced by Takara Shuzo) by using DNA ligase. A PPS-deficient strain AT2572-1 of Escherichia coli (see J. Bacteriol. , 96 , 2185 (1968), obtained from E . coli Genetic Stock Center (the above-mentioned address)) was transformed with the ligation reaction mixture. Transformants were spread on a plate containing ampicillin to select grown ampicillin-resistant strains from which a strain growable on a minimum medium by using pyruvic acid as a carbon source was selected. Plasmid DNA was extracted from the strain, and the obtained plasmid was designated as pTWV-pps. A restriction enzyme cleavage map was analyzed for an insert DNA fragment of pTWV-pps obtained as described above, and the PPS activity of the obtained transformant was measured. According to results of the analysis and the measurement, it was confirmed that the DNA fragment contained the pps gene . Example 2: Production of L-Threonine <1> Creation of L-threonine-producing bacterium pTWV-pps obtained in Example 1 was introduced into an L-threonine-producing bacterium, Escherichia coli VKPM B-3996 strain (described in United States Patent No. 5,175,107, and deposited since November 19, 1987 under a registration number of RIA 1867 in All-Union Scientific Center of Antibiotics (VNIIA) (Nagatinskaya Street 3-a, 113105 Moscow, Russian Federation)). A transformant was selected on the basis of Sm r and Ap r to obtain B-3996/pTWV-pps. The VKPM B-3996 strain harbors a plasmid pVIC40 (streptomycin resistance (Sm r )) containing threonine operon having a gene coding for aspartokinase in which feedback inhibition by L-threonine is desensitized. <2> Evaluation of L-threonine productivity B-3996 strain and B-3996/pTWV-pps.were cultivated at 37°C for 24 hours by using an L-threonine-producing medium (containing 40 g of glucose, 16 g of ammonium sulfate, 1 g of potassium primary phosphate, 1 g of magnesium sulfate heptahydrate, 0.01 g of ferrous sulfate heptahydrate, 0.01 g of manganese chloride tetrahydrate, 2 g of yeast extract, and 40 g of calcium carbonate in 1 L of water, pH = 7.0). L-Threonine contained in the medium was quantitatively determined by means of high performance liquid chromatography. Results are shown in Table 3. Bacterial strain Amount of produced L-threonine (q/L) B-3996 14.5 B-3996/pTWV-pps 15.5 Example 3: Production of L-Isoleucine <1> Creation of L-isoleucine-producing bacterium (1) Construction of plasmid containing threonine operon and pps gene A plasmid pVIC40 containing threonine operon having a gene coding for aspartokinase desensitized with feedback inhibition by L-threonine (described in United States Patent No. 5,175,107) was digested with Bam HI, and an obtained fragment was blunt-ended by using Klenow fragment. On the other hand, the Sal I fragment of 3.3 kbp containing the pps gene obtained in Example 1 was blunt-ended in the same manner as described above, and it was ligated with the pVIC40 fragment described above. The ligation reaction solution was used to transform Escherichia coli PPS-deficient strain to select a transformant exhibiting Sm r and pps + . A recombinant plasmid was extracted from the transformant, and it was designated as pVIC40-pps (17.9 kb). (2) Construction of plasmid containing ilvGMEDA operon Chromosomal DNA was extracted from Escherichia coli MI162 strain. The chromosomal DNA was digested with restriction enzyme Hind III. It has been revealed that a Hind III- Hind III DNA fragment containing the ilvGM gene has a length of 4.8 kb. Accordingly, a Hind III- Hind III DNA fragment having a length in the vicinity of 4.8 kb was ligated with a DNA fragment obtained by digesting a plasmid vector pBR322 (purchased from Takara Shuzo) with Hind III. An obtained DNA ligation reaction mixture was introduced into Escherichia coli MI262 (CGSC5769) strain as an acetohydroxyacid synthase-deficient strain. A transformed strain, in which the character of deficiency of acetohydroxyacid synthase was complemented, was selected. A plasmid harbored by the strain was isolated. As a result of analysis of the structure of the plasmid, a DNA fragment of 4.8 kb containing the ilvGM gene and a part of the 5'-terminal side of the ilvE gene was inserted at the Hind III site of pBR322. The plasmid was designated as pBRGM7. Synthetic oligonucleotides described in SEQ ID NO: 6 and SEQ ID NO: 7 in Sequence Listing were synthesized with reference to a nucleotide sequence of the ilvGM gene reported in Gene , 97 , 21 (1991); Proc. Natl. Acad. Sci. U.S.A. , 78 , 922 (1981); and J. Bacteriol ., 149 , 294 (1982). A sequence containing promoter, attenuator, and an ilvGM gene-coding region of the nucleotide sequence of the ilvGM gene is depicted in SEQ ID NO: 5 together with an amino acid sequence of the coding region. The both oligonucleotides were used as primers to amplify DNA in accordance with the PCR method by using chromosomal DNA of MI162 strain as a template. The DNA fragment to be amplified is a DNA fragment having a sequence from 25th nucleotide to 952th nucleotide of the nucleotide sequence depicted in SEQ ID NO: 5 in Sequence Listing. This fragment was designated as "fragment (A)". Synthetic oligonucleotides described in SEQ ID NO: 8 and SEQ ID.NO: 9 in Sequence Listing were synthesized with reference to the nucleotide sequence reported in Gene , 97 , 21 (1991); Proc. Natl. Acad. Sci. U.S.A. , 78 , 922 (1981); and J. Bacteriol. , 149 , 294 (1982), in the same manner as described above. The both oligonucleotides were used as primers to amplify DNA in accordance with the PCR method by using chromosomal DNA of MI162 strain as a template. The DNA fragment to be amplified is a DNA fragment having a sequence from 1161th nucleotide to 2421th nucleotide of the nucleotide sequence depicted in SEQ ID NO: 5 in Sequence Listing. This fragment was designated as "fragment (B)". A large fragment obtained by digesting the fragment (A) with Sma I was ligated with a DNA fragment obtained by digesting a vector pUC18 (Takara Shuzo) with Sma I to prepare a plasmid pUCA. A large fragment obtained by digesting the fragment (B) with Kpn I was ligated with a large fragment obtained by digesting pHSG399 (Takara Shuzo) with Hinc I and Kpn I to prepare a plasmid pHSGB. The plasmid pUCA was digested with Kpn I, and the digested end was blunt-ended by using large fragment (Klenow fragment) of DNA polymerase I, followed by digestion with PstI to finally isolate a DNA fragment containing the fragment (A). The plasmid pHSGB was digested with Hind III, and the digested end was blunt-ended by using large fragment (Klenow fragment) of DNA polymerase I, followed by digestion with Pst I to finally isolate a DNA fragment containing the fragment (B). The both DNA fragments were ligated with each other to prepare a plasmid pHSGSK. The Sma I- Kpn I fragment, which was carried on pHSGSK and originated from the fragments (A) and (B), was designated as "fragment (C)". The fragment (C) corresponds to a fragment obtained by digesting the Hind III- Hind III fragment of 4.8 kb containing the ilvGM gene with Sma I and Kpn I, which contains promoter, SD sequence, and upstream region of the ilvG gene, but which lacks a sequence of about 0.2 kb ranging from leader sequence to attenuator region. The procedure for constructing pHSGSK as described above is summarized in Fig. 1. The fragment (C) was obtained by digesting the plasmid pHSGSK with Sma I and Kpn I. A large DNA fragment was obtained by digesting the plasmid pBRGM7 with Sma I and Kpn I. The both fragments were ligated with each other. An obtained plasmid was designated as pdGM1. A Hind III- Hind III fragment of 4.6 kb containing the ilvGM gene, which is carried on pdGM1, lacks the region necessary for attenuation. The ilvGM gene, which lacks the region necessary for attenuation, is expressed as "ΔattGM" in this Example and the drawings. The procedure for constructing pdGM1 as described above is summarized in Fig. 2. A plasmid pDRIA4, which is described in Japanese Laid-Open Patent Publication No. 2-458, is autonomously replicable in bacteria belonging to the genus Escherichia . The plasmid pDRIA4 is prepared by combining a shuttle vector pDR1120 autonomously replicable in bacteria belonging to the genus Brevibacterium with a Bam HI- Bam HI fragment containing ilvA gene coding for threonine deaminase originating from E. coli K-12 and a part of the 3'-terminal side of ilvD gene. The Bam HI- Bam HI fragment is described to be 2.3 kb in Japanese Laid-Open Patent Publication No. 2-458. However, at present, the Bam HI- Bam HI fragment has been revealed to be 2.75 kb. The plasmid pDRIA4 exists out of the chromosomal DNA of Brevibacterium flavum AJ12358 (FERM P-9764) or Brevibacterium flavum AJ12359 (FERM P-9765). The plasmid pDRIA4 can be prepared from these strains in accordance with an ordinary method. A Hind III- Bam HI fragment containing the ilvA gene coding for threonine deaminase substantially desensitized with inhibition by L-isoleucine was prepared from the Bam HI- Bam HI DNA fragment of 2.75 kb on the plasmid pDRIA4. The Hind III- Bam HI fragment was ligated with a DNA fragment obtained by digesting a vector pMW119 (produced by Nippon Gene) with Hind III and Bam HI. A plasmid thus prepared was designated as pMWA1. A DNA fragment obtained by digesting the plasmid pMWA1 with HindIII was ligated with a DNA fragment containing the ilvGM gene obtained by digesting the plasmid pdGM1 with Hind III. A plasmid, in which the ilvGM gene had the same transcription direction as the transcription direction of the ilvA gene, was selected by analyzing the position of the restriction enzyme recognition site existing on the plasmid. The obtained plasmid was designated as pMWGMA2. pMWGMA2 has the ilvGM gene from which attenuator is removed, a part of the 5'-terminal side of the ilvE gene, and a part of the 3'-terminal side of the ilvD gene. The procedure for constructing pMWGMA2 as described above is summarized in Fig. 3. Chromosomal DNA of Escherichia coli MI162 strain was prepared, which was digested with Sal I and Pst I to prepare a DNA fragment mixture. On the other hand, a vector pUC19 (Takara Shuzo) was digested with Sal I and Pst I to prepare a DNA fragment. The DNA fragment mixture was ligated with the DNA fragment obtained by digesting pUC19 to obtain a DNA mixture. This DNA mixture was introduced into AB2070 strain as a transaminase B-deficient strain (J. Bacteriol. , 109 , 703 (1972), allotted from E. coli Genetic Stock Center, CGSC2070) to select a transformed strain recovered with branched amino acid auxotrophy. When a plasmid was prepared from the obtained strain, the DNA fragment obtained by digesting the plasmid pUC19 with Sal I and Pst I was ligated with the Sal I- Pst I DNA fragment containing the ilvE gene. This plasmid was designated as pUCE1. pUCE1 includes a part of the 3'-terminal side of the ilvM gene, the ilvE gene, and a part of the 5'-terminal side of the ilvD gene. pMWGMA2 was partially digested with Hind III to prepare a DNA fragment mixture. On the other hand, pUCE1 was digested with Hind III to prepare a Hind III- Hind III DNA fragment of 1.7 kb containing part of the ilvE gene and a part of the 5'-terminal side of the ilvD gene. The both were ligated with each other to obtain a DNA mixture which was used to transform a dihydroxyacid dehydratase (ilvD gene product)-deficient strain, i.e., AB1280 strain. A transformant strain, from which the branched chain amino acid auxotrophy disappeared, was selected from transformed strains. When a plasmid was prepared from the obtained transformant strain, a DNA fragment obtained by digesting pMWGMA2 only at the Hind III site existing between ΔattGM and ilvA was ligated with the Hind III- Hind III DNA fragment of 1.7 kb originating from pUCE1 and containing a part of the ilvE gene and a part of the ilvD gene, in which ilvGMEDA operon was regenerated. The plasmid thus obtained was designated as pMWD5. The procedure for constructing pMWD5 as described above is summarized in Fig. 4. The plasmid pMWD5 (Ap r ) obtained as described above is a plasmid based on the use of pMW119 as a vector, which carries ilvGMEDA operon from which the region necessary for attenuation is removed. (3) Creation of L-isoleucine-producing bacterium pVIC40-pps was introduced into Escherichia coli VNIIGenetika TDH-6 (TDH-6 strain corresponds to a host bacterium obtained by deleting the plasmid pVIC40 from Escherichia coli VKPM B-3996 strain described above) to select a transformant by using Sm r as an index. Further, pMWD5 was introduced thereinto to obtain a transformant TDB-6/pVIC40-pps,pMWDS exhibiting Sm r and Ap r . On the other hand, pVIC40 and pMWD5 were introduced into TDH-6 described above by using Sm r and Ap r as indexes to obtain TDH-6/pVIC40,pMWD5. <2> Evaluation of L-isoleucine productivity TDH-6/pVIC40-pps,pMWD5 was cultivated at 37 °C for 24 hours by using an L-isoleucine-producing medium (containing 40 g of glucose, 16 g of ammonium sulfate, 1 g of potassium primary phosphate, 1 g of magnesium sulfate heptahydrate, 0.01 g of ferrous sulfate heptahydrate, 0.01 g of manganese chloride tetrahydrate, 2 g of yeast extract, and 40 g of calcium carbonate in 1 L of water, pH = 7.0). TDH-6/pVIC40,pMWD5 was cultivated as a control in the same manner as described above. L-Isoleucine contained in the medium was quantitatively determined by means of high performance liquid chromatography. Results are shown in Table 4. Bacterial strain Amount of produced L-isoleucine (g/L) TDH-6/pVIC40,pMWD5 10.0 TDH-6/pVIC40-pps,pMWD5 11.5 Industrial Applicability According to the present invention, it is possible to produce, at a high yield, the amino acids L-threonine and L-isoleucine. The productivity of these L-amino acids can be further enhanced by applying the present invention to microorganism having a high productivity of these L-amino acids. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: AJINOMOTO CO., INC. (ii) TITLE OF INVENTION: METHOD FOR PRODUCING L-AMINO ACID (iii) NUMBER OF SEQUENCES: 9 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: AJINOMOTO CO., INC. (B) STREET: 15-1, Kyobashi 1-chome, Chuo-ku (C) CITY: Tokyo (E) COUNTRY: Japan (F) ZIP: 104 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: 96927917.3 (B) FILING DATE: 27.08.96 (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: JP 7-221561 (B) FILING DATE: 30-AUG-1995 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: JP 8-200860 (B) FILING DATE: 30-JUL-1996 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Strehl Schubel-Hopf & Partner (B) REGISTRATION NUMBER: (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: [49](89)223911 (B) TELEFAX: [49] (89)223915 (2) INFORMATION FOR SEQ ID NO:1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: (2) INFORMATION FOR SEQ ID NO: 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: YES (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: (2) INFORMATION FOR SEQ ID NO: 5 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2841 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Escherichia coli (B) STRAIN: MI162 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 957..1055 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1081..1104 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1195..2841 (ix) FEATURE: (A) NAME/KEY : cleavage-site (SmaI) (B) LOCATION: 52..57 (ix) FEATURE: (A) NAME/KEY: cleavage-site (KpnI) (B) LOCATION: 2395..2400 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: (2) INFORMATION FOR SEQ ID NO : 7 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: YES (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 bases (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "synthetic DNA" (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: YES (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:

Claims: A method for producing L-amino acid comprising the steps of cultivating, in a medium, a microorganism having an ability to produce the L-amino acid, producing and accumulating the L-amino acid in the medium, and collecting the L-amino acid, wherein said L-amino acid is L-threonine or L-isoleucine, and an activity of phosphoenolpyruvate synthase In microbial cells is enhanced as compared with a wild strain. The method according to claim 1, wherein the microorganism is a bacterium belonging to the genus Escherichia. The method according to claim 1, wherein the microorganism is a coryneform bacterium. The method according to any one of claims 1 to 3, wherein the activity of phosphoenolpyruvate synthase in microbial cells is enhanced by increasing an amount of expression ofa phosphoenolpyruvate synthase gene in the microbial cells. The method according to claim 4, wherein the amount of expression of the phosphoenolpyruvate synthase gene is increased by increasing a copy number of the gene. The method according to claim 5, wherein the microorganism is a recombinant strain which is transformed with the phosphoenolpyruvate synthase genre.

Inventors: ITO HISAO, IZUI MASAKO, KISHINO HIROKO, KURAHASHI OSAMU, ONO YUKIKO, ITO, HISAO, IZUI, MASAKO, KISHINO, HIROKO, KURAHASHI, OSAMU, ONO, YUKIKO, ITO, Hisao Ajinomoto Co., Inc. Central Research, IZUI, Masako Ajinomoto Co., Inc. Central, KISHINO, Hiroko Ajinomoto Co., Inc. Central, KURAHASHI, Osamu Ajinomoto Co., Inc. Central, ONO, Yukiko Ajinomoto Co., Inc. Central Research
Applicants: AJINOMOTO KK, AJINOMOTO CO., INC.
Application year: 1996
Main classification: C12P13
IPC codes: C12P13, C12R1, C12N15